236 related articles for article (PubMed ID: 2849248)
1. [Treatment of gastrointestinal neuroendocrine tumors with the somatostatin analog octreotide (Sandostatin)].
Stöckmann F; Creutzfeldt W
Z Gastroenterol; 1988 Oct; 26(10):665-75. PubMed ID: 2849248
[TBL] [Abstract][Full Text] [Related]
2. [Somatostatin analogue in the treatment of neuroendocrine gut tumors].
Ben Yosef R; Glaser B; Catane R
Harefuah; 1990 Jul; 119(1-2):15-8. PubMed ID: 2172125
[TBL] [Abstract][Full Text] [Related]
3. [Somatostatin analogues in treatment of gastrointestinal and pancreatic neuroendocrine tumors].
Simonenko VB; Dulin PA; Makanin MA
Klin Med (Mosk); 2006; 84(4):4-8. PubMed ID: 16755846
[TBL] [Abstract][Full Text] [Related]
4. Future medical prospects for Sandostatin.
Harris AG
Z Gastroenterol; 1990 Sep; 28 Suppl 2():55-60. PubMed ID: 1980778
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
Arnold R; Neuhaus C; Trautmann ME
Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
[No Abstract] [Full Text] [Related]
6. An important new treatment for carcinoid tumors and VIPomas.
Oncology (Williston Park); 1988 Dec; 2(12):35-6. PubMed ID: 2856315
[No Abstract] [Full Text] [Related]
7. Effects of sandostatin on neuroendocrine tumours of the gastrointestinal system.
Buchanan KD
Recent Results Cancer Res; 1993; 129():45-55. PubMed ID: 8394596
[TBL] [Abstract][Full Text] [Related]
8. [Somatostatin analog (octreotide) in clinical use: current and potential indications].
Meier R; Dierdorf R; Gyr K
Schweiz Med Wochenschr; 1992 Jun; 122(25):957-68. PubMed ID: 1621078
[TBL] [Abstract][Full Text] [Related]
9. The role of somatostatin analogs in the treatment of endocrine gastrointestinal tumors.
Trautmann ME; Neuhaus C; Lenze H; Benning R; Benning M; Dennler HJ; Bruns C; Joseph K; Arnold R
Horm Metab Res Suppl; 1993; 27():24-7. PubMed ID: 8392487
[No Abstract] [Full Text] [Related]
10. Sandostatin and the Belfast experience.
Buchanan KD; Collins JS; Varghese A; Johnston CF; Shaw C
Digestion; 1990; 45 Suppl 1():11-4; discussion 15-6. PubMed ID: 2159429
[TBL] [Abstract][Full Text] [Related]
11. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological treatment of gastroenteropancreatic apudomas with an analog of somatostatin, SMS 201-995 (octreotide)].
Varas Lorenzo MJ
Rev Esp Enferm Dig; 1991 Feb; 79(2):95-8. PubMed ID: 2059523
[TBL] [Abstract][Full Text] [Related]
13. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.
Modlin IM; Pavel M; Kidd M; Gustafsson BI
Aliment Pharmacol Ther; 2010 Jan; 31(2):169-88. PubMed ID: 19845567
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
Williams G; Anderson JV; Williams SJ; Bloom SR
Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoid tumors].
Tóth M; Prónai L; Németh AM; Tulassay Z
Orv Hetil; 2002 May; 143(19 Suppl):1087-92. PubMed ID: 12063867
[TBL] [Abstract][Full Text] [Related]
16. [Somatostatin analogues for the treatment of gastro-entero-pancreatic neuroendocrine tumours].
Uomo G; Germano D; Rabitti PG
Minerva Endocrinol; 2001 Dec; 26(4):225-9. PubMed ID: 11782707
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
Baradari V; Huether A; Höpfner M; Schuppan D; Scherübl H
Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
[TBL] [Abstract][Full Text] [Related]
18. [The pharmacological treatment of digestive endocrine tumors with the somatostatin analog SMS 201-995].
Varas Lorenzo MJ
Rev Clin Esp; 1991 Jan; 188(1):4-6. PubMed ID: 2063026
[TBL] [Abstract][Full Text] [Related]
19. Debut of a somatostatin analog: octreotide in review.
Zindel LR
Conn Med; 1989 Dec; 53(12):741-4. PubMed ID: 2558839
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of carcinoid tumor with a long-acting somatostatin analog].
Werling K; Lengyel G; Fehér E; Jakab Z; Besznyák I; Feher J
Orv Hetil; 1993 Feb; 134(6):301-5. PubMed ID: 8430017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
